Presentations + Publications Search presentations Presentation J.P. Morgan Healthcare Conference 2025 Corporate Presentation January 15, 2025 Presentation Potent in vivo CAR T cell generation and durable antitumor activity in preclinical models using VivoVec, a surface-engineered lentiviral vector platform May 19, 2023 Publication Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering Journal for ImmunoTherapy of Cancer March 16, 2023 Presentation VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance in vivo CAR T cell generation and antitumor activity November 11, 2022 Presentation Synthetic Receptor Enabled Differentiation (ShRED), a novel platform for manufacturing of iPSC-derived cytotoxic innate lymphocytes for “off-the-shelf” cancer immunotherapies November 11, 2022
